Within the tumor microenvironment of HCC, FABP5 fosters lipid accumulation in monocytes/macrophages, modifies programmed death-ligand 1 (PD-L1) expression in regulatory T cells, and promotes immune tolerance 40. Here, FABP5 is linked to hepatocellular carcinoma.